Llama Allergy: What the Absence of Published Data Actually Tells You
Llama allergy is an IgE-mediated reaction to proteins in llama dander, saliva, and urine. No WHO/IUIS allergens have been designated for llamas, and no published case reports of isolated llama allergy exist. Cross-reactivity with alpacas and camels is biologically expected via conserved lipocalin and albumin families. Growing exposure through therapy-animal and trekking contexts makes patient guidance necessary despite the data void.
Free · 5 min · Insurance accepted
Key facts
No WHO/IUIS-named allergens exist for Lama glama (llama) — zero peer-reviewed studies have specifically characterized llama-derived IgE-reactive proteins as named allergens.
Llama sensitization is expected to cross-react with camel (Camelus) albumin through serum albumin homology, as both are Camelidae species and albumin is the primary aeroallergen from mammalian dander sources.
Less than 1 percent of allergy patients encounter llamas — sensitization is restricted to agricultural workers, hobbyist breeders, zoo staff, and the approximately 158,000 US llama and alpaca owners.
Llama fiber (wool) processing occupationally exposes shearers and textile workers to aerosolized dander proteins — occupational rhinitis and asthma from llama fiber dust is the most clinically recognized exposure route.
What Is Llama Allergy — and Why Is the Literature Essentially Empty?
Llama allergy refers to IgE-mediated immune reactions to proteins in llama dander, saliva, and urine.
Llamas (Lama glama) are domesticated South American camelids that have spread globally as fiber animals, trekking companions, and increasingly — in the United States and Europe — as therapy animals used in hospice visits, pediatric hospital programs, and outdoor therapeutic hiking contexts.
Despite growing llama populations and expanding human exposure, the allergen literature for llamas is essentially empty: no allergen proteins have been designated by the WHO/IUIS nomenclature committee (the international body that names allergens like Fel d 1 for cats or Der p 1 for dust mites), and no published peer-reviewed case reports of isolated llama allergy exist in the accessible medical literature.
This absence of data is not the same as an absence of allergenic potential. All mammals produce lipocalins, serum albumins, and other proteins capable of sensitizing the human immune system. The absence of published llama case reports more likely reflects the relative rarity of llama ownership compared to cats or dogs, the lack of occupational exposure in high-income country research settings, and the overall research gap for New World camelids. It does not mean llama allergy cannot occur.
The practical clinical guidance must therefore be extrapolated from the camelid family context: the alpaca (which also lacks WHO/IUIS allergens but represents the same New World camelid allergy framework) and the camel (which has the most published camelid data, including extract-level cross-reactivity with cow, goat, sheep, and deer dander).
Llama Allergy Symptoms: What Extrapolation Predicts
Recognizing symptoms early helps you get the right treatment faster.
Rhinitis and sneezing
mildExpected primary symptom based on camelid family pattern; runny, itchy nose appearing within minutes of live llama contact or exposure to unprocessed llama fiber dust.
Allergic conjunctivitis
mildRed, watery, itchy eyes expected from aerosolized llama dander in enclosed farm or therapy animal settings.
Contact urticaria
mildLocalized hives at skin contact points with llama saliva or dander; expected in individuals with cross-reactive IgE from pre-existing cat, dog, or horse sensitization.
Mechanical skin irritation from fiber
mildNon-immune itching and redness from contact with coarser-grade llama fiber; resolves when removed and does not involve IgE antibodies. Distinguished from true allergy by lack of systemic or respiratory symptoms.
Asthma or bronchospasm
moderatePotential asthma trigger in sensitized individuals with pre-existing asthma, by analogy with other camelid and farm animal dander allergens in enclosed ventilation-limited spaces.
When to see a doctor
Because no published case series of llama allergy exists, the expected symptom profile is extrapolated from the camelid family and from other farm animal dander allergies with comparable protein profiles. This is honest pattern-based inference, not fabricated clinical data. Expected llama allergy symptoms, by analogy with alpaca dander allergy and camelid cross-reactivity data: Rhinitis, sneezing, and nasal congestion are the most commonly anticipated first symptoms, appearing within minutes of close contact with live llamas — consistent with any mammalian dander IgE-mediated reaction. Allergic conjunctivitis (red, watery, itchy eyes) typically accompanies rhinitis in animal dander allergy. Urticaria (hives) at skin contact sites — hands, face, or anywhere llama saliva contacts skin — may occur in sensitized individuals. In individuals with pre-existing asthma, bronchospasm from inhaled camelid allergens in enclosed spaces is a realistic concern by analogy with other farm animal dander allergies. If you experience any respiratory difficulty, throat tightening, or widespread systemic symptoms after llama contact, seek emergency medical evaluation. Though no anaphylaxis case from llama exposure has been published, the theoretical risk exists for highly sensitized atopic individuals.
Llama Allergy and Asthma: What Camelid Biology Predicts
Although no published case of llama-triggered asthma exists in the accessible literature, the asthma risk is not zero. By analogy with alpaca (where farm worker asthma is an anticipated occupational risk), camel (where occupational asthma in herders is documented), and the broader farm animal dander allergy literature, llama dander aerosolized in enclosed barns or limited-ventilation therapy settings is a plausible asthma trigger in sensitized individuals. The risk is most relevant for individuals who already have allergic asthma triggered by cat, dog, or horse dander, because the same cross-reactive lipocalin and albumin IgE could recognize llama proteins. Close contact with therapy llamas in enclosed hospital corridors or small therapy rooms may generate meaningful dander loads for sensitized atopic patients. For children with asthma participating in llama-assisted therapy programs, parents and program coordinators should discuss the allergy history with program staff and the child's allergist before enrollment — a precaution that applies to any therapy animal program involving mammalian species.
Potential Complications of Llama Allergy
Given the data void, complication predictions are extrapolated from the camelid and farm animal allergy literature. The expected complication profile for llama allergy mirrors that of other mild-to-moderate animal dander allergies.
Delayed diagnosis from data void
Because llama is not recognized as a common allergen, clinicians and patients may not identify it as the cause of rhinitis or skin symptoms, leading to months of undiagnosed exposure and continued sensitization.
Cross-reactive sensitization to other camelids
Once sensitized to llama lipocalin or albumin proteins, cross-reactive IgE may respond to alpacas, camels, and potentially other ruminant species sharing conserved protein families, broadening exposure risk.
Occupational asthma from sustained farm exposure
Llama farm workers and trekking guides with high daily dander exposure and unmanaged atopy are at risk of progressing from rhinitis to asthma over months to years, consistent with all farm animal dander allergy patterns.
Reactions at therapy animal events
Atopic children or immunocompromised patients encountering llama therapy programs without pre-assessment may develop unexpected allergic reactions in settings not prepared for allergy management.
What Causes Llama Allergy? Dander, Saliva, and Expected Cross-Reactivity
Like all camelids, llamas produce allergenic proteins in dander (shed skin cells), saliva, and urine. These proteins — primarily in the lipocalin superfamily and the serum albumin family — are the molecular mediators of IgE-mediated allergic reactions. When individuals with atopic predisposition are repeatedly exposed to llama proteins, the immune system can produce IgE antibodies that mount a response on subsequent exposures.
Llama (domesticated New World camelid, primary species)
Lama glama
Alpaca (closest New World camelid relative, expected cross-reactivity)
Vicugna pacos
Guanaco (wild ancestor of the llama, rare exposure context)
Lama guanicoe
Dromedary camel (Old World camelid with demonstrated extract-level cross-reactivity with cow and deer dander)
Camelus dromedarius
How it works
In IgE-mediated llama allergy, the immune system produces specific IgE antibodies against conserved camelid lipocalin or serum albumin proteins on initial exposures. These IgE antibodies bind to mast cells throughout mucosal surfaces. Re-exposure to llama dander crosslinks surface IgE, triggering immediate mast cell degranulation with histamine and leukotriene release — producing rhinitis, conjunctivitis, urticaria, or bronchospasm within minutes. The mechanism is identical to cat, dog, or horse dander allergy, driven by the same conserved protein families.
Two key facts guide clinical extrapolation for llamas. First, extract-level cross-reactivity between camel dander and cow, goat, sheep, and deer dander has been demonstrated experimentally (Nahm et al. 1996; Spitzauer et al. 1997), reflecting the highly conserved nature of mammalian serum albumin across related species. Llama albumin, as a camelid species, would be expected to fit this cross-reactive pattern. Second, Hilger et al. (Allergol Select 2024) concluded that no scientific evidence supports the existence of truly hypoallergenic furred pets — all mammals produce allergenic proteins regardless of fur characteristics.
Llamas are New World camelids (family Camelidae, subfamily Laminae), sharing the same evolutionary branch as alpacas and vicunas. Old World camelids (dromedary and Bactrian camels) diverged from New World camelids approximately 25 million years ago, meaning intra-New-World cross-reactivity between llamas and alpacas is expected to be stronger than cross-reactivity with Old World camelids — though no species-comparative IgE inhibition study has confirmed this.
Llama fiber is used in textiles and shares alpaca fiber's low-lanolin characteristic. As with alpaca, processed llama fiber products are lower-risk than live-animal dander exposure because processing removes biological residue.
Risk factors to watch for
Pre-existing cat, dog, or horse allergy
Lipocalin and serum albumin sensitization from common pets creates a cross-reactive IgE profile likely to recognize conserved camelid proteins — the most important risk factor for llama-naive individuals encountering therapy llamas or farm settings.
Therapy animal program participation
Llamas are increasingly used in pediatric hospital, hospice, and outdoor therapeutic settings — creating close contact exposures in populations that may include atopic children and immunocompromised adults.
Farm, trekking, or agritourism exposure
Llama trekking events and farm stays generate direct dander, saliva, and urine exposure far exceeding what a brief casual encounter involves, particularly in enclosed spaces.
Atopic background
Atopy — the genetic predisposition to produce IgE against environmental proteins — is the single strongest risk factor for sensitization to any new animal allergen, including llamas.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Llama Allergy: Working With Incomplete Tools
Llama allergy diagnosis faces the same fundamental challenge as alpaca allergy: no WHO/IUIS allergen designations exist, no standardized llama-specific skin test extract is commercially available, and no llama-specific ImmunoCAP assay exists. The diagnostic toolkit for llamas is limited. In practice, an allergist suspecting llama allergy would approach diagnosis through several routes. First, a thorough clinical history correlating symptoms to llama exposure timeline. Second, skin prick testing using fresh llama dander or hair, or using the FDA-licensed camel hair extract (the most closely related species with a licensed diagnostic product). A positive wheal response combined with consistent exposure history supports the diagnosis. Third, specific IgE blood testing using camel hair or cross-reactive animal dander panels (cat, dog, horse, guinea pig) to identify whether lipocalin or albumin sensitization exists that predicts camelid cross-reactivity. At-home allergy testing services such as Curex can screen for IgE to 40+ common allergens, providing a valuable baseline of cat, dog, and environmental sensitization status before a specialist consultation. If your panel shows cat or dog lipocalin sensitization, a predisposition to camelid cross-reactivity is plausible. The honest clinical position is that a definitive llama-specific IgE confirmation is not currently achievable with commercially available tools. Diagnosis relies on clinical correlation, cross-reactive panel results, and — in some cases — a supervised exposure observation with emergency equipment available.
Skin Prick Test with Camelid Extract
Fresh llama dander or FDA-licensed camel hair extract is placed on the forearm and the skin lightly pricked. A wheal 3 mm or more than negative control suggests camelid sensitization. No standardized llama-specific extract is commercially available.
Specific IgE Blood Panel (Cross-reactive Animal Danders)
Testing for IgE to camel hair, cat (Fel d 4 lipocalin), dog (Can f 1, 2), and horse (Equ c 1) can identify lipocalin sensitization patterns that predict camelid cross-reactivity without llama-specific test components.
Supervised Clinical Exposure Observation
Under allergist supervision with emergency equipment present, controlled time-limited contact with a llama while monitoring for clinical reaction. Used when history and blood testing are inconclusive and allergy confirmation matters for occupational or therapeutic decisions.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
Patients who cannot avoid llama exposure — whether due to farm ownership, therapy-animal program involvement, or occupational necessity — may find that the immunotherapy landscape, while not studied for llamas specifically, offers meaningful options through the camelid cross-reactivity framework. For those with co-existing cat, dog, dust mite, or grass pollen allergy, SLIT (sublingual immunotherapy) is the most accessible entry point. Sublingual drops offered through providers like Curex, starting at $39/month, address the most common IgE-mediated allergens that typically co-exist in atopic individuals seeking llama allergy management. Because llama albumin and lipocalin proteins share conserved epitopes with cat and dog proteins via the broader mammalian allergen family (Spitzauer et al. 1997; Nahm et al. 1996), reducing IgE reactivity against these common anchoring allergens can lower the cross-reactive threshold for camelid exposures as well. For individuals requiring llama-specific desensitization — occupational llama farmers or therapy-animal handlers for whom SLIT for co-allergens is insufficient — a board-certified allergist can prepare custom camelid dander extract using FDA-licensed camel hair extract as the compounding base. Subcutaneous immunotherapy (SCIT) follows the same build-up/maintenance protocol established for other farm animal dander allergies: weekly injections for 3-6 months, then monthly maintenance for 3-5 years. Clinical improvement typically becomes perceptible within 6-12 months of consistent treatment. The absence of llama-specific controlled trials means all immunotherapy guidance for this species is extrapolated, but the camelid protein biology is sufficiently well understood to make this extrapolation clinically reasonable.
Establish the sensitization profile
Skin prick testing with camel hair extract and a comprehensive animal dander panel maps cross-reactive IgE before immunotherapy planning.
Design the extract
Custom camelid dander extract is prepared using FDA-licensed camel hair extract as the closest available standardized starting material.
Build-up phase
Weekly injections at progressively increasing doses over 3-6 months; the immune system is trained to tolerate camelid proteins without full IgE activation.
Maintenance and review
Monthly maintenance injections for 3-5 years; annual IgE retesting tracks response trajectory and guides treatment duration.
“Animal dander immunotherapy studies show 60-85% of patients experience significant symptom reduction; llama-specific data does not exist”
Treat your Llama allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Llama Allergy: Practical Guidance for a Data-Void Species
Living with llama allergy is largely a matter of informed caution combined with the same practical tools used for any animal dander allergy. The data void should not cause either undue anxiety (there are no published severe llama anaphylaxis cases) or false reassurance (the absence of data is not proof of safety). For most people — consumers of processed llama textiles, tourists on llama trekking tours, or parents at petting zoos — the risk profile is low and manageable. Antihistamine availability for planned encounters, awareness of cross-reactive potential from existing cat or dog allergy, and avoidance of enclosed spaces with multiple llamas during shearing season are practical guideposts. For those with occupational or sustained exposure, building the same evidence base that exists for cat, dog, and horse allergy is the right long-term approach: formal allergy testing, an allergist relationship, and immunotherapy evaluation if symptoms are persistent.
Therapy llama programs: guidance for healthcare staff
Therapy llama visits to hospitals and care facilities should include pre-screening of participants for existing animal allergies. Visits in well-ventilated spaces reduce allergen accumulation. Participants with cat or dog allergy should be counseled on potential cross-reactive risk before close contact.
Trekking and farm visit preparations
Antihistamines taken 30-60 minutes before llama contact provide meaningful symptom reduction for mildly reactive individuals. For known moderate sensitivity, discuss your allergy status with your allergist before booking trekking events or farm stays where avoidance will not be possible.
Understanding the camelid cross-reactivity web
If you have llama allergy, caution around alpacas and potentially camels is warranted — the conserved protein families shared among camelids predict cross-reactivity. The alpaca page and camel page in this collection provide the full camelid framework including the camel milk CMA alternative story.
Seasonal Patterns
January - December
low intensity
Prevention Tips
Pre-screen atopic individuals before therapy llama programs
Healthcare settings hosting llama therapy visits should ask participants about pre-existing cat, dog, or farm animal allergies before close contact — atopic individuals are at elevated cross-reactive risk.
Use N95 respirators in llama barns
Enclosed barn settings concentrate airborne dander significantly; fitted N95 respirators reduce inhalation exposure by more than 90% for farm workers and frequent visitors.
Wash hands after llama contact
Llama saliva on hands can cause localized urticaria if transferred to the face; handwashing immediately after handling reduces this risk.
Pre-medicate before planned trekking or farm visits
Taking a non-sedating antihistamine 30-60 minutes before planned llama contact reduces symptom severity in mildly sensitized individuals.
Test before farm investment
Individuals considering llama farming or trekking businesses who have existing atopic allergies should undergo allergy testing — including broad animal dander panels — before significant investment in the enterprise.
Prognosis for Llama Allergy
The prognosis for llama allergy is expected to be favorable based on the mild severity designation and the management principles that transfer well from related animal dander allergies. No severe llama allergy cases are documented in the published literature, and the exposure contexts — occasional farm visits, trekking, and therapy programs — generally allow avoidance or pre-medication strategies without major quality-of-life impact. Occupational cases with sustained daily dander exposure represent the higher-risk scenario, as with all farm animal dander allergies. Early recognition, appropriate pharmacotherapy, and respiratory protection prevent most cases from progressing to asthma. Immunotherapy through camelid extract is available for escalating cases. The most clinically important intervention is correct identification of llama as the allergen source. The data void means that practitioners may not consider it promptly, allowing avoidable ongoing sensitization. Patients who know their reactions follow llama contact should advocate for allergy testing even in the absence of commercially available llama-specific tests.
Key takeaways
No published case reports of isolated llama allergy exist, but the absence of data is not proof of safety — all mammals produce allergenic proteins.
Cross-reactivity with alpacas, camels, and via shared albumin with other ruminants is biologically expected and should guide clinical caution.
The data-void status does not preclude diagnosis — camel hair extract SPT, cross-reactive animal dander panels, and clinical history together support a working diagnosis.
Therapy animal programs involving llamas should pre-screen participants for existing cat, dog, or farm animal allergies to reduce unexpected reactions.
When a llama farmer or alpaca rancher presents with new respiratory symptoms, the clinical approach is identical to large-animal veterinarian occupational allergy. No specific extract exists so I use camel and horse panels to map the cross-reactive Camelidae allergen profile.
Frequently Asked Questions
Yes, llama allergy is possible and should be expected based on basic mammalian allergen biology. All mammals produce lipocalin and serum albumin proteins capable of triggering IgE-mediated allergic reactions in predisposed individuals. The fact that no published case reports of isolated llama allergy exist in the medical literature more likely reflects the relative rarity of close human-llama contact in high-income research contexts than a genuine absence of allergenicity. If you develop rhinitis, conjunctivitis, urticaria, or respiratory symptoms consistently after llama contact, a board-certified allergist can evaluate you for camelid sensitization even without llama-specific commercial test components.
They are expected to be closely related but not necessarily identical. Llamas (Lama glama) and alpacas (Vicugna pacos) are both New World camelids and diverged relatively recently in evolutionary terms, sharing highly conserved lipocalin and serum albumin protein families. Cross-reactivity between their allergens is biologically predicted. However, no controlled IgE inhibition study has directly compared llama and alpaca allergen profiles, so the exact degree of cross-reactivity is unknown. Patients sensitized to one New World camelid should exercise appropriate caution around the other. Alpacas have a slightly more developed allergy literature, with commercial camel hair extract available for testing and a published scientific context around fiber marketing claims.
Therapy llamas can trigger allergic reactions in atopic individuals, particularly those already sensitized to cat, dog, or horse dander through cross-reactive lipocalin and albumin epitopes. The therapy context introduces an additional risk factor: participants in hospital or care facility therapy programs may include immunocompromised patients, elderly individuals, or children with pre-existing atopy who have not been screened for animal allergy. Close physical contact with a llama in a small indoor room generates meaningful dander exposure. Healthcare facilities running therapy animal programs should include animal allergy screening in participant intake and maintain anti-allergy supplies (antihistamines, and for confirmed anaphylaxis-risk patients, epinephrine access) on hand.
Like alpaca fiber, llama fiber is sometimes marketed as hypoallergenic, particularly for the low-lanolin characteristic shared across the camelid family. This marketing claim has the same weak scientific basis as alpaca hypoallergenic claims. Hilger et al. (Allergol Select 2024) concluded that no scientific evidence supports the existence of truly hypoallergenic furred pets or their fiber products. Processed llama fiber is lower-risk than live-animal dander exposure because processing removes protein residue — but it is not immune to causing reactions in highly sensitized individuals. The softer grades of llama fiber (comparable to alpaca baby grade in fiber diameter) cause less mechanical skin irritation than coarser grades, but this is a fiber physics matter, not an immunology one.
Llama dander could theoretically trigger asthma in sensitized individuals with pre-existing allergic airway disease, based on direct analogy with other farm animal dander allergens. No published llama asthma case exists in the literature, but the mechanism — lipocalin and albumin proteins aerosolized from dander reaching the lower airways of IgE-sensitized atopic individuals — is exactly the same as documented asthma-triggering mechanisms for cat, dog, horse, and cow dander. Farm workers spending many hours daily in enclosed llama barns represent the highest-risk occupational scenario. Individuals with moderate-to-severe allergic asthma who have regular llama contact should discuss this exposure with their allergist.
The most reliable method is temporal correlation: do your symptoms consistently appear after llama contact and resolve when the exposure ends? If so, llama allergens are the primary candidate. However, distinguishing llama-specific sensitization from cross-reactive IgE driven by pre-existing cat or dog allergy requires allergy testing. A positive skin prick test with camel hair extract, combined with a clear exposure history, supports camelid sensitization. If your cat and dog IgE tests show lipocalin sensitization (Fel d 4 or Can f 1/2), that cross-reactive profile also predicts llama reactivity. An allergist experienced in unusual animal exposures can interpret these patterns in the context of your specific history.
Contact the school in advance and communicate your child's animal allergy status, specifically noting that camelid (llama/alpaca) allergy can cross-react with cat and dog sensitization. Request details about the visit format — enclosed indoor versus open outdoor space, duration of close contact, and whether touching is mandatory. For a child with mild sensitivity, pre-medication with a non-sedating antihistamine 30-60 minutes before the visit and hand washing after contact is a reasonable precaution. For a child with moderate-to-severe animal dander allergy or asthma, discuss the risk level with your pediatric allergist before the visit rather than making a solo risk assessment.
No commercial ImmunoCAP test or standardized skin test extract exists specifically for llama allergens. The closest available diagnostic tool is the FDA-licensed camel hair extract for skin prick testing, which can be used by analogy given the camelid family cross-reactivity. Fresh llama dander can also be prepared as a custom skin test material in specialized allergy labs. Specific IgE blood testing using broad animal dander panels (cat, dog, guinea pig, horse) may detect cross-reactive lipocalin or albumin sensitization that predicts camelid reactivity without a llama-specific component. A board-certified allergist familiar with unusual animal exposures can guide this diagnostic workup.
Medical References
- [1]Nahm DH et al. Occupational asthma due to deer dander: cross-reactivity with cow, goat, sheep, camel and horse. Allergy. 1996;51(5):344-347.
- [2]Spitzauer S et al. Characterization of dog allergens by means of immunoblotting. Int Arch Allergy Immunol. 1997;112:132-139.
- [3]Hilger C et al. No scientific evidence for truly hypoallergenic furred pets. Allergol Select. 2024.
- [4]American Academy of Allergy, Asthma and Immunology. Animal allergy overview. AAAAI.org.
- [5]El-Agamy EI et al. Camel milk proteins: a review. Small Ruminant Research. 2009;82(1):1-6.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Llama allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.